Topical antibacterial and combined therapy of pyoderma and complicated atopic dermatitis with mupirocin



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Clinical efficacy of topical mupirocin in pyoderma and atopic dermatitis complicated with bacterial infection was established.

Full Text

Restricted Access

About the authors

O G Elisyutina

Institute of Immunology

Email: el-olga@yandex.ru
Moscow, Russia

E S Fedenko

Institute of Immunology

Moscow, Russia

O V Shtyrbul

Institute of Immunology

Moscow, Russia

References

  1. Масюкова С.А., Гладько В.В. Устинов М.В. и соавт. Бактериальные инфекции кожи и их значение в клинической практике дерматолога. Cons. Med. 2004, № 3, с. 180-186.
  2. Новосёлов В.С., Плиева Л.Р. Пиодермии. Рос. Аллергол. Журн. 2004, № 5, с. 33-38.
  3. Казначеева Л.Ф., Молокова А.В., Казначеев К.С. Профилактика вторичного инфицирования кожи у детей с атопическим дерматитом. Рациональная терапия и уход. Рос. Аллергол. Журн. 2005, № 3, с. 82-86.
  4. Аллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР-Медиа». 2009, 656 с.
  5. Wolf R., Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin. Dermatol. 2012, v. 30 (3), p. 329-334.
  6. Breuer K., Kapp A., Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001, v. 56, p.1034-1041.
  7. Ong P.Y., Ohtake T., Brandt C. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med., 2002, v. 347, p. 1199-2000.
  8. Arikawa J. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients withatopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol. 2002, v. 119 (2), p. 433-439.
  9. Bieber Т. Atopic Dermatitis. Mechanisms of Disease. N. Engl. J. Med. 2008, v. 358, p. 1483-1494.
  10. Hauk D.J., Hamid Q.A., Chrousos G.P., Leung D.Y.M. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunolog. 2000, v. 105 (4), p. 782-787.
  11. Akdis C., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/ American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J. Allergy Clin. Immunol. 2006, v. 118, p. 152-169.
  12. Van Rijen M., Bonten M., Wenzel R., Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers Cochrane Database Syst Rev. 2008, v. 8 (4), CD006216.
  13. Gong J.Q., Lin L., Lin T. et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 2006, v. 155 (4), p. 680-687.
  14. Breuer K., Haussler S., Kapp A., Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 2002, v. 147 (1), p. 55-61.
  15. Lever R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br. J. Dermatol. 1988, v. 119 (2), p. 189-198.
  16. Савицкая Л.Н. Клинико-иммунологические особенности патогенеза, течения, терапии фурункулеза в Казахстане (клинико-экспериментальное исследование). Диссертация д-ра мед. наук. Семипалатинск. 1987.
  17. Hanifin J., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venerol. (Stockh). 1980, v. 114 (Suppl), p. 44-47.
  18. Stadler J.F., Taieb A. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report ofthe European task force on atopic dermatitis. Dermatology. 1993, v. 186, p. 23-31.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies